Masaaki Miyata

Prof. Masaaki Miyata


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MMMasaaki Miyata
Masaaki Miyata
KMKoki Matsushita
Koki Matsushita
RSRyunosuke Shindo
Ryunosuke Shindo
YSYutaro Shimokawa
Yutaro Shimokawa
YSYoshimasa Sugiura
Yoshimasa Sugiura
Michiaki YamashitaMichiaki Yamashita
Michiaki Yamashita
Selenoneine is a novel organic selenium compound markedly found in the blood, muscles, and other tissues of fish. This study aimed to determine whether selenoneine attenuates hepatocellular injury and hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD). Mice lacking farnesoid X receptor (FXR) were used as a model for fatty liver disease, because they exhibited hepatomegaly, hepatic steatosis, and hepatic inflammation. Fxr-null mice were fed a 0.3 mg Se/kg selenoneine-containing diet for four months. Significant decreases in the levels of hepatomegaly, hepatic damage-associated diagnostic markers, hepatic triglycerides, and total bile acids were found in Fxr-null mice fed with a selenoneine-rich diet. Hepatic and blood clot total selenium concentrations were 1.7 and 1.9 times higher in the selenoneine group than in the control group. A marked accumulation of selenoneine was found in the liver and blood clot of the selenoneine group. The expression levels of oxidative stress-related genes (heme oxygenase 1 (Hmox1), glutathione S-transferase alpha 1 (Gsta1), and Gsta2), fatty acid synthetic genes (stearoyl CoA desaturase 1(Scd1) and acetyl-CoA carboxylase 1 (Acc1)), and selenoprotein (glutathione peroxidase 1 (Gpx1) and selenoprotein P (Selenop)) were significantly decreased in the selenoneine group. These results suggest that selenoneine attenuates hepatic steatosis and hepatocellular injury in an NAFLD mouse model.

2 August 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
YSYoshimasa Sugiura
Yoshimasa Sugiura
MUMasakatsu Usui
Masakatsu Usui
HKHirotaka Katsuzaki
Hirotaka Katsuzaki
KIKunio Imai
Kunio Imai
MKMakoto Kakinuma
Makoto Kakinuma
MMMasaaki Miyata
Masaaki Miyata
Phlorotannin is the collective term for polyphenols derived from brown algae belonging to the genera Ascopyllum, Ecklonia, Eisenia, Fucus and Sargassum etc. Since the incidence of allergies is currently increasing in the world, there is a focus on phlorotannins having anti-allergic and anti-inflammatory effects. In this study, six purified phlorotannins (eckol; 6,6′-bieckol; 6,8′-bieckol; 8,8′-bieckol; phlorofucofuroeckol (PFF)-A and PFF-B) from Eisenia arborea, orally administered to mice, were examined for their suppression effects on ear swelling. In considering the suppression, we also examined whether the phlorotannins suppressed release of chemical mediators (histamine, leukotriene B4 and prostaglandin E2), and mRNA expression and/or the activity of cyclooxygenase-2 (COX-2), using RBL-2H3 cells, a cultured mast cell model. Results showed that the phlorotnannins exhibited suppression effects in all experiments, with 6,8′-bieckol, 8,8′-bieckol and PFF-A showing the strongest of these effects. In conclusion, orally administered phlorotannins suppress mouse ear swelling, and this mechanism apparently involves suppression of chemical mediator release and COX-2 mRNA expression or activity. This is the first report of the anti-allergic effects of the orally administered purified phlorotannins in vivo. Phlorotannins show potential for use in functional foods or drugs.

1 January 2014 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MMMasaaki Miyata
Masaaki Miyata
THTatsuya Hata
Tatsuya Hata
YYYasushi Yamazoe
Yasushi Yamazoe
Kouichi YoshinariKouichi Yoshinari
Kouichi Yoshinari

1 January 2020 in The Journal of Toxicological Sciences
Verified
Journal Article
Open access
PDF file
MMMasaaki Miyata
Masaaki Miyata
AFAkihiro Funaki
Akihiro Funaki
CFChiaki Fukuhara
Chiaki Fukuhara
YSYukino Sumiya
Yukino Sumiya
YSYoshimasa Sugiura
Yoshimasa Sugiura
Mice lacking the farnesoid X receptor (FXR) are used as a genetic model for nonalcoholic fatty liver disease because their livers exhibit hepatic steatosis and inflammation. The influence of taurine drinking on disrupted hepatic function was investigated using female Fxr-null mice. Significant decreases in the levels of hepatic damage-associated diagnostic markers, hepatic triglycerides, non-esterified fatty acids, and total bile acids were found in Fxr-null mice that had drunk water containing 0.5% taurine for four weeks. Hepatic but not serum taurine concentrations were significantly increased in these mice. The expression levels of oxidative stress-related genes (Hmox1 and Gsta1) and fatty acid synthetic genes (Acc1 and Scd1) were significantly decreased in these mice. These results suggest that drinking taurine improves hepatic steatosis and dysfunction caused by a lack of FXR.

8 February 2016 in Fisheries Science
Verified
Journal Article
Closed access
PDF file
YSYoshimasa Sugiura
Yoshimasa Sugiura
YKYuichi Kinoshita
Yuichi Kinoshita
MAMahiko Abe
Mahiko Abe
NMNoboru Murase
Noboru Murase
RTRyusuke Tanaka
Ryusuke Tanaka
MMMasaaki Miyata
Masaaki Miyata

1 August 2013 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MMMasaaki Miyata
Masaaki Miyata
HYHiroki Yamakawa
Hiroki Yamakawa
KHKenjiro Hayashi
Kenjiro Hayashi
HKHideaki Kuribayashi
Hideaki Kuribayashi
YYYasushi Yamazoe
Yasushi Yamazoe
Kouichi YoshinariKouichi Yoshinari
Kouichi Yoshinari